Leal T, et al. Identifying resistance to immune checkpoint inhibitors by screening for PD-L1 and MHC I expression on CTCS in pts with NSCLC. IASLC 2018; abstract P3.04-08.
ASCO GI 2020: nieuwe GE-behandelingen gepaard met betere kwaliteit van leven
apr 2020 | Maag-darm-leveroncologie